MoneySeptember 15, 2026via SiliconAngle
Startup Evvy raises $40M to accelerate precision diagnostics and medicine for women’s health
Why it matters
A healthcare AI startup raises meaningful capital to scale a diagnostics platform. Practitioners in healthtech and VCs tracking AI-in-medicine will note the round size and investor mix; enthusiasts tracking AI funding velocity see another data point in the biotech/diagnostics boom.
Key signals
- Series B round: $40M
- Lead investor: Catalio Capital Management
- New investors: U.S. Fertility Innovation Fund, Rethink Impact, Muse Capital, Alumni Ventures
- Focus: AI-powered precision diagnostics and care platform for women's health
- Announced: September 15, 2026
- Series B: $40M
- Focus: AI precision diagnostics and care platform for women's health
- Date: September 15, 2026
The hook
$40M. Evvy just closed its Series B to scale AI-powered women's health diagnostics — betting precision medicine is the wedge into a fragmented market.
Evvy, an artificial intelligence startup that’s looking to enhance women’s healthcare, said today it has closed on $40 million in Series B funding to scale its precision diagnostics and care platform. The round was led by Catalio Capital Management, with new investors including the U.S. Fertility In…